{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T20:36:47Z","timestamp":1761165407249,"version":"build-2065373602"},"reference-count":25,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2012,11,1]],"date-time":"2012-11-01T00:00:00Z","timestamp":1351728000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["jgisurgery.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Gastrointestinal Surgery"],"published-print":{"date-parts":[[2012,11]]},"DOI":"10.1007\/s11605-012-2019-y","type":"journal-article","created":{"date-parts":[[2012,9,4]],"date-time":"2012-09-04T16:33:56Z","timestamp":1346776436000},"page":"2120-2125","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Comparison Between Living Donor Liver Transplantation Recipients Who Met the Milan and UCSF Criteria After Successful Downstaging Therapies"],"prefix":"10.1016","volume":"16","author":[{"given":"J.Y.","family":"Lei","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.N.","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1007\/s11605-012-2019-y_bb0010","first-page":"74","article-title":"Global cancer statistics, 2003","volume":"55","author":"Parkin","year":"2005","journal-title":"CA Cancer J Clin"},{"key":"10.1007\/s11605-012-2019-y_bb0015","first-page":"S72","article-title":"Hepatocelluar carcinoma: an epidemiologic view","volume":"35","author":"EI-Serag","year":"2002","journal-title":"ClinGastroenterol"},{"key":"10.1007\/s11605-012-2019-y_bb0020","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1102\/1470-7330.2012.0011","article-title":"Interventional therapies for hepatocellular carcinoma","volume":"12","author":"Willatt","year":"2012","journal-title":"Cancer Imaging."},{"issue":"11","key":"10.1007\/s11605-012-2019-y_bb0025","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJM199603143341104","article-title":"Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis","volume":"334","author":"Mazzaferro","year":"1996","journal-title":"N Engl J Med."},{"key":"10.1007\/s11605-012-2019-y_bb0030","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1053\/jhep.2001.24563","article-title":"Liver transplantation for hepatocellur carcinoma: expansion of the tumor size limites does not adversely impact survival","volume":"6","author":"Yao","year":"2001","journal-title":"Hepatology."},{"issue":"9","key":"10.1007\/s11605-012-2019-y_bb0035","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1053\/jlts.2002.34892","article-title":"Liver transplantation for hepatocellular carcinoma: comparison of the proposed UCSF criteria with the Milan criteria and the Pittsburgh modified TNM criteria","volume":"8","author":"Yao","year":"2002","journal-title":"Liver transplantation"},{"key":"10.1007\/s11605-012-2019-y_bb0040","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1097\/00000658-199810000-00005","article-title":"Liver transplantation for hepatocellular carcinoma: a registry report of the impact of tumor characteristics on outcome","volume":"228","author":"Klintmalm","year":"1998","journal-title":"Ann Surg"},{"key":"10.1007\/s11605-012-2019-y_bb0045","first-page":"188","article-title":"Liver transplantation in the treatment of primary liver cancer","volume":"37","author":"Yokoyama","year":"1990","journal-title":"Hepatogastroenterology"},{"key":"10.1007\/s11605-012-2019-y_bb0050","unstructured":"United Network for Organ Sharing. Liver transplant candidate with hepatocelluar carcinoma. Policy 3.6.4.4, September 18, 2007. http:\/\/www.unos.org\/policiesandbylaws\/ policies. asp. Accessed February 2009"},{"issue":"6","key":"10.1007\/s11605-012-2019-y_bb0055","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1016\/j.transproceed.2012.05.033","article-title":"Living donor liver transplantation for hepatocellular carcinoma","volume":"44","author":"Isik","year":"2012","journal-title":"Transplant Proc."},{"key":"10.1007\/s11605-012-2019-y_bb0060","doi-asserted-by":"crossref","first-page":"791013","DOI":"10.4061\/2011\/791013","article-title":"Live resection after downstaging hepatocellular carcinoma with sorafenib","volume":"2011","author":"Barbier","year":"2011","journal-title":"Int J Hepato"},{"issue":"8","key":"10.1007\/s11605-012-2019-y_bb0065","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1111\/j.1600-6143.2009.02695.x","article-title":"A comparative analysis of transarterial downstaging for hepatocelluar carcinoma: chemoembolization versus radioembolization","volume":"9","author":"Lewandowski","year":"2009","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1007\/s11605-012-2019-y_bb0070","doi-asserted-by":"crossref","first-page":"955","DOI":"10.3748\/wjg.v13.i6.955","article-title":"Clinical study on safety of adult-to-adult living donor liver transplantation in both donors and recipients","volume":"13","author":"Liu","year":"2007","journal-title":"World J Gastroenterol."},{"key":"10.1007\/s11605-012-2019-y_bb0075","first-page":"605","article-title":"Treatment of hepatocellular carcinoma","author":"Nguyen","year":"2003"},{"issue":"3","key":"10.1007\/s11605-012-2019-y_bb0080","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1002\/lt.21994","article-title":"Morphological feature of advanced hepatocellular carcinoma as a predictor of downstaging and liver transplantation: an intention-to-treat analysis","volume":"16","author":"Barakat","year":"2010","journal-title":"Liver Transpl."},{"issue":"4","key":"10.1007\/s11605-012-2019-y_bb0085","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/SLA.0b013e31818a07d4","article-title":"Outcomes of neoadjuvant transarterial chemoemblization to downstage hepatocellular carcinoma before liver transplantation","volume":"248","author":"Chapman","year":"2008","journal-title":"Ann Surg"},{"key":"10.1007\/s11605-012-2019-y_bb0090","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/j.1600-6143.2009.02576.x","article-title":"Transarterial chemoinfusion for hepatocellular carcinoma as downstaging therapy and a bridge toward liver transplantation","volume":"9","author":"De Luna","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1007\/s11605-012-2019-y_bb0095","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1002\/hep.22412","article-title":"Excellent outcome following down-staging of hepatocellular carcinoma prior to liver transplantation: an intention-to-treat analysis","volume":"48","author":"Yao","year":"2008","journal-title":"Hepatology"},{"key":"10.1007\/s11605-012-2019-y_bb0100","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1111\/j.1600-6143.2008.02409.x","article-title":"Liver transplantation for hepatocellular carcinoma: results of down-staging in patients initially outside the Milan selection criteria","volume":"8","author":"Ravaioli","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1007\/s11605-012-2019-y_bb0105","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1097\/00000658-199712000-00006","article-title":"Influence of preoperative transarterial lipiodol chemoembolization on resection and transplantation for hepatocellular carcinoma in patients with cirrhosis","volume":"226","author":"Majno","year":"1997","journal-title":"Ann Surg"},{"issue":"Suppl 2","key":"10.1007\/s11605-012-2019-y_bb0110","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.1002\/lt.22335","article-title":"Does a patient qualify for liver transplantation after the down-staging of hepatocellular carcinoma","volume":"17","author":"Yao","year":"2011","journal-title":"Liver Transpl"},{"issue":"3","key":"10.1007\/s11605-012-2019-y_bb0115","first-page":"242","article-title":"Current status of molecularly targeted therapy for hepatocellular carcinoma: clinical practice","volume":"15","author":"Kudo","year":"2010","journal-title":"Int J ClinOncol."},{"issue":"1 Pt.1","key":"10.1007\/s11605-012-2019-y_bb0120","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gcb.2007.11.001","article-title":"Use of Sorafenib (Nexavar) in the treatment of hepatocellular carcinoma: PRODIGEAFEF recommendations","volume":"32","author":"Boige","year":"2008","journal-title":"Gastroenterol Clin Biol"},{"issue":"4","key":"10.1007\/s11605-012-2019-y_bb0125","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1056\/NEJMoa0708857","article-title":"Sorafebib in advanced hepatocelluar carcinoma","volume":"359","author":"Liovet","year":"2008","journal-title":"N Eng J Med."},{"issue":"5","key":"10.1007\/s11605-012-2019-y_bb0130","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1097\/SLA.0b013e3181896278","article-title":"Liver transplantation for hepatocellular carcinoma under calcineurin inhibitors: reassessment of risk factors for tumor recurrence","volume":"248","author":"Vivarelli","year":"2008","journal-title":"Ann Surg."}],"container-title":["Journal of Gastrointestinal Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-012-2019-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11605-012-2019-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23050977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1091255X23050977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11605-012-2019-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T19:40:54Z","timestamp":1761075654000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1091255X23050977"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2012,11]]}},"alternative-id":["S1091255X23050977"],"URL":"https:\/\/doi.org\/10.1007\/s11605-012-2019-y","relation":{},"ISSN":["1091-255X"],"issn-type":[{"type":"print","value":"1091-255X"}],"subject":[],"published":{"date-parts":[[2012,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison Between Living Donor Liver Transplantation Recipients Who Met the Milan and UCSF Criteria After Successful Downstaging Therapies","name":"articletitle","label":"Article Title"},{"value":"Journal of Gastrointestinal Surgery","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s11605-012-2019-y","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2012 Society for Surgery of the Alimentary Tract. Published by ELSEVIER INC. All rights reserved. Published by Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}